Healthcare Governance and Climate Change Adaptation: A Pharmaceutical Industry Perspective

摘要: The 4th assessment report of the Intergovernmental Panel on Climate Change (IPCC) concludes that ‘the global burden disease and premature deaths’ are somewhat contributed by climate change (IPCC, Introduction to working group II – fourth report. In: Parry ML, Canziani OF, Palutikof JP, van der Linden PJ, Hanson CE (eds) 2007: impacts, adaptation vulnerability. Cambridge University Press, Cambridge, pp 1–6, 2007). extant literature scientific evidence public health also suggest could create one biggest challenges its future governance. This does not only have profound impact sector services but poses significant threats private service providers. One establishments tend become directly affected is pharmaceutical industry. Given scenario uncertainty risk associated with change, this industry appears be in a unique albeit intricate situation as it faces both risks opportunities consequence change. As entails aversion opportunity utilisation, may, therefore, considered useful study relation exposure subsequent measures. paramount importance social environmental implications, issue governance becomes an indispensible part any such study. Following scrutiny recent chapter aims present strategies adopted role government managing or moderating these considered.